Alzheimer's Disease (AD) is a progressive neurodegenerative disorder that effects 50 million
people worldwide. In this review, AD pathology and the development of novel therapeutic …

Recently, great attention was paid on the synthesis of nano particles via green protocols,
explicitly using plant materials. In view of this, currently, zinc oxide nano particles (ZnO NPs) …

Structural derivatization of natural products has been a continuing and irreplaceable source
of novel drug leads. Natural phenols are a broad category of natural products with wide …

Cholinesterase enzymes such as acetylcholinesterase (AChE) and butyrylcholinesterase
(BuChE) cause hydrolysis of acetylcholine (ACh), a neurotransmitter responsible for the …

Fifteen flavonoids isolated from the Eupatorium adenophorum showed inhibitory activities
against acetylcholinesterase (AChE) isolated from Caenorhabditis elegans and Spodoptera …

Alzheimer's disease (AD) which is associated with cognitive dysfunction and memory lapse
has become a health concern. Various targets and pathways have been involved in AD's …

Pleiotropic interference may be a prerequisite for the efficient limitation of the progression of
multi-factorial diseases such as Alzheimer's disease (AD). Concept of designing the single …

Investigating the drug-AChE binding mechanism is vital in understanding its cogent use in
medical practice against Alzheimer's disease (AD). The production and accumulation of …

Abstract In view of Multi-Target Directed Ligand (MTDL) approach in treating Alzheimer's
Disease (AD), a series of novel quinazolinone and vanillin cyanoacetamide based …

This study aims at the synthesis and initial biological evaluation of novel rhenium–
tricarbonyl complexes of 3, 3′, 4′, 5, 7-pentahydroxyflavone (quercetin), 3, 7, 4΄ …